Gene chip co Affymetrix to buy $330 million eBioscience
This article was originally published in Scrip
Executive Summary
Affymetrix, known for its genomic analysis tools for discovery and genetic testing and also as a pioneer gene chip company, has taken another step to diversify and agreed to buy privately held eBioscience for $330 million in cash.